Additionally, lung cancer patients with high ANLN expression had shorter overall survival(OS), disease-free interval(DFI), and progression-free interval(PFI) compared to those with lower expression levels (Zhang L. et al., 2023). This evidence concerns the gene ANLN and lung cancer.